Table of Contents Author Guidelines Submit a Manuscript
Pulmonary Medicine
Volume 2012, Article ID 791234, 9 pages
http://dx.doi.org/10.1155/2012/791234
Review Article

Cigarette-Smoke-Induced Dysregulation of MicroRNA Expression and Its Role in Lung Carcinogenesis

Department of Molecular, Cellular and Developmental Biology, Yale University, P.O. Box 208103, New Haven, CT 06520, USA

Received 27 May 2011; Accepted 19 October 2011

Academic Editor: Helmut H. Popper

Copyright © 2012 Rebecca Russ and Frank J. Slack. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, R. Siegel, J. Xu, and E. Ward, “Cancer statistics, 2010,” CA Cancer Journal for Clinicians, vol. 60, no. 5, pp. 277–300, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. X. Wu, M. G. Piper-Hunter, M. Crawford et al., “MicroRNAs in the pathogenesis of lung cancer,” Journal of Thoracic Oncology, vol. 4, no. 8, pp. 1028–1034, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. K. Shedden, J. M. G. Taylor, S. A. Enkemann et al., “Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study,” Nature Medicine, vol. 14, no. 8, pp. 822–827, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. M. Meyerson and D. Carbone, “Genomic and proteomic profiling of lung cancers: lung cancer classification in the age of targeted therapy,” Journal of Clinical Oncology, vol. 23, no. 14, pp. 3219–3226, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. C. Z. Chen, “MicroRNAs as oncogenes and tumor suppressors,” The New England Journal of Medicine, vol. 353, no. 17, pp. 1768–1771, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. G. R. Pottelberge, P. Mestdagh, K. R. Bracke et al., “MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease,” The American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 7, pp. 898–906, 2010. View at Google Scholar
  7. A. Esquela-Kerscher and F. J. Slack, “Oncomirs: microRNAs with a role in cancer,” Nature Reviews Cancer, vol. 6, no. 4, pp. 259–269, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. A. Izzotti, G. A. Calin, P. Arrigo, V. E. Steele, C. M. Croce, and S. De Flora, “Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke,” FASEB Journal, vol. 23, no. 3, pp. 806–812, 2009. View at Publisher · View at Google Scholar · View at PubMed
  9. F. Schembri, S. Sridhar, C. Perdomo et al., “MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 7, pp. 2319–2324, 2009. View at Publisher · View at Google Scholar · View at PubMed
  10. G. A. Calin and C. M. Croce, “MicroRNA signatures in human cancers,” Nature Reviews Cancer, vol. 6, no. 11, pp. 857–866, 2006. View at Publisher · View at Google Scholar · View at PubMed
  11. D. F. Church and W. A. Pryor, “Free-radical chemistry of cigarette smoke and its toxicological implications,” Environmental Health Perspectives, vol. 64, pp. 111–126, 1985. View at Google Scholar · View at Scopus
  12. A. Valavanidis, T. Vlachogianni, and K. Fiotakis, “Tobacco smoke: involvement of reactive oxygen species and stable free radicals in mechanisms of oxidative damage, carcinogenesis and synergistic effects with other respirable particles,” International Journal of Environmental Research and Public Health, vol. 6, no. 2, pp. 445–462, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. G. A. Calin, C. Sevignani, C. D. Dumitru et al., “Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 9, pp. 2999–3004, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. A. Izzotti, P. Larghero, R. Balansky, U. Pfeffer, V. E. Steele, and S. De Flora, “Interplay between histopathological alterations, cigarette smoke and chemopreventive agents in defining microRNA profiles in mouse lung,” Mutation Research, vol. 717, no. 1-2, pp. 17–24, 2011. View at Google Scholar
  15. N. Fujimoto, M. Wislez, J. Zhang et al., “High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptor,” Cancer Research, vol. 65, no. 24, pp. 11478–11485, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. R. Duan, C. H. Pak, and P. Jin, “Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA,” Human Molecular Genetics, vol. 16, no. 9, pp. 1124–1131, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. L. He, X. He, L. P. Lim et al., “A microRNA component of the p53 tumour suppressor network,” Nature, vol. 447, no. 7148, pp. 1130–1134, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. S. A. Ahrendt, J. T. Chow, S. C. Yang et al., “Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer,” Cancer Research, vol. 60, no. 12, pp. 3155–3159, 2000. View at Google Scholar · View at Scopus
  19. K. Kondo, H. Tsuzuki, M. Sasa, M. Sumitomo, T. Uyama, and Y. Monden, “A dose-response relationship between the frequency of p53 mutations and tobacco consumption in lung cancer patients,” Journal of Surgical Oncology, vol. 61, no. 1, pp. 20–26, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Chiba, T. Takahashi, and M.M. Nau, “Mutations in the P53 gene are frequent in primary, resected non-small cell lung cancer Chiba I, Takahashi T, Nau MM Et Al. NCI-Navy Medical Oncology Branch, National Cancer Institute, National Naval Medical Center, Bethesda, MD 20814. Oncogene 1990;5:1603–1610,” Lung Cancer, vol. 7, no. 4, p. 265, 1991. View at Google Scholar
  21. P. Hainaut and G. P. Pfeifer, “Patterns of p53→T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke,” Carcinogenesis, vol. 22, no. 3, pp. 367–374, 2001. View at Google Scholar · View at Scopus
  22. L. He, X. He, S. W. Lowe, and G. J. Hannon, “microRNAs join the p53 network: another piece in the tumour-suppression puzzle,” Nature Reviews Cancer, vol. 7, no. 11, pp. 819–822, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. N. Raver-Shapira, E. Marciano, E. Meiri et al., “Transcriptional activation of miR-34a contributes to p53-mediated apoptosis,” Molecular Cell, vol. 26, no. 5, pp. 731–743, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. S. Roush and F. J. Slack, “The let-7 family of microRNAs,” Trends in Cell Biology, vol. 18, no. 10, pp. 505–516, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. S. M. Johnson, H. Grosshans, J. Shingara et al., “RAS is regulated by the let-7 microRNA family,” Cell, vol. 120, no. 5, pp. 635–647, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. A. A. Russo, L. Tong, J. O. Lee, P. D. Jeffrey, and N. P. Pavletich, “Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16(INK4a),” Nature, vol. 395, no. 6699, pp. 237–243, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. C. D. Johnson, A. Esquela-Kerscher, G. Stefani et al., “The let-7 microRNA represses cell proliferation pathways in human cells,” Cancer Research, vol. 67, no. 16, pp. 7713–7722, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. F. J. Slack and J. B. Weidhass, “MicroRNAs as a potential magic bullet in cancer,” Future Oncology, vol. 2, no. 1, pp. 73–82, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. R. Yao, Y. Wang, F. D'Agostini et al., “K-ras mutations in lung tumors from p53 mutant mice exposed to cigarette smoke,” Experimental Lung Research, vol. 31, no. 2, pp. 271–281, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. A. Izzotti, M. Bagnasco, C. Cartiglia et al., “Chemoprevention of genome, transcriptome, and proteome alterations induced by cigarette smoke in rat lung,” European Journal of Cancer, vol. 41, no. 13, pp. 1864–1874, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. A. Izzotti, G. A. Calin, V. E. Steele, C. M. Croce, and S. De Flora, “Relationships of microRNA expression in mouse lung with age and exposure to cigarette smoke and light,” FASEB Journal, vol. 23, no. 9, pp. 3243–3250, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. A. Izzotti, R. M. Balansky, A. Camoirano et al., “Birth-related genomic and transcriptional changes in mouse lung: modulation by transplacental N-acetylcysteine,” Mutation Research—Reviews in Mutation Research, vol. 544, no. 2-3, pp. 441–449, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Balansky, G. Ganchev, M. Iltcheva, V. E. Steele, F. D'Agostini, and S. De Flora, “Potent carcinogenicity of cigarette smoke in mice exposed early in life,” Carcinogenesis, vol. 28, no. 10, pp. 2236–2243, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. M. Yee, P. F. Vitiello, J. M. Roper et al., “Type II epithelial cells are critical target for hyperoxia-mediated impairment of postnatal lung development,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 291, no. 5, pp. L1101–L1111, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. S. De Flora, S. Scarfì, A. Izzotti et al., “Induction by 7,12-dimethylbenz(a)anthracene of molecular and biochemical alterations in transformed human mammary epithelial stem cells, and protection by N-acetylcysteine,” International Journal of Oncology, vol. 29, no. 3, pp. 521–529, 2006. View at Google Scholar · View at Scopus
  36. A. Izzotti, P. Larghero, M. Longobardi et al., “Dose-responsiveness and Persistence of MicroRNA Expression Alterations Induced by Cigarette Smoke in Mouse Lung,” Mutation Research, vol. 717, no. 1-2, pp. 9–16, 2011. View at Google Scholar
  37. A. Izzotti, R. M. Balansky, C. Cartiglia, A. Camoirano, M. Longobardi, and S. De Flora, “Genomic and transcriptional alterations in mouse fetus liver after transplacental exposure to cigarette smoke,” FASEB Journal, vol. 17, no. 9, pp. 1127–1129, 2003. View at Google Scholar · View at Scopus
  38. A. Izzotti, C. Cartiglia, M. Longobardi et al., “Alterations of gene expression in skin and lung of mice exposed to light and cigarette smoke,” FASEB Journal, vol. 18, no. 13, pp. 1559–1561, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. S. Deflora, F. Dagostini, R. Balansky et al., “High susceptibility of neonatal mice to molecular, biochemical and cytogenetic alterations induced by environmental cigarette smoke and light,” Mutation Research—Reviews in Mutation Research, vol. 659, no. 1-2, pp. 137–146, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Tobacco Smoke and Involuntary Smoking, vol. 84, International Agency for Research on Cancer. World Health Organization, 2004.
  41. J. Lu, G. Getz, E. A. Miska et al., “MicroRNA expression profiles classify human cancers,” Nature, vol. 435, no. 7043, pp. 834–838, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. A. Izzotti, G. A. Calin, V. E. Steele et al., “Chemoprevention of cigarette smoke-induced alterations of microRNA expression in rat lungs,” Cancer Prevention Research, vol. 3, no. 1, pp. 62–72, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. J. Krutzfeldt, N. Rajewsky, R. Braich et al., “Silencing of microRNAs in vivo with ‘antagomirs’,” Nature, vol. 438, no. 7068, pp. 685–689, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. G. Meister, M. Landthaler, Y. Dorsett, and T. Tuschl, “Sequence-specific inhibition of microRNA-and siRNA-induced RNA silencing,” RNA, vol. 10, no. 3, pp. 544–550, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. N. E. Kohl, S. D. Mosser, S. J. DeSolms et al., “Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor,” Science, vol. 260, no. 5116, pp. 1934–1937, 1993. View at Google Scholar · View at Scopus
  46. C. Arteaga, “Targeting HER1/EGFR: a molecular approach to cancer therapy,” Seminars in Oncology, vol. 30, no. 3, pp. 3–14, 2003. View at Google Scholar · View at Scopus
  47. B. E. Johnson and J. V. Heymach, “Farnesyl transferase inhibitors for patients with lung cancer,” Clinical Cancer Research, vol. 10, no. 12, pp. 4254S–4257S, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus